Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2024.02.08

A scenic view of Sai Life Sciences' Integrated Discovery & Development Campus in Hyderabad, featuring modern research buildings, a lush green landscape, and a serene water body with floating lily pads, symbolizing the company’s commitment to sustainability and eco-friendly operations.

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability and the journey so far. Read the full report here.

Making this announcement, Krishna Kanumuri, CEO & Managing Director, stated, “I am delighted to present our fourth successive Sustainability Report, reflecting our commitment to the sustainability journey and to conduct our business responsibly. In 2023, we reset our Sustainable Development Goals to attain specific Environmental, Social, and Governance (ESG) targets by March 31, 2027. The learnings and insights gleaned from our previous experience have shaped our SDGs for this phase, reflecting confidence in our ability to strive for and achieve more ambitious targets.”

The fourth report released by Sai Life Sciences highlights significant progress in various areas:

Environmental:

  • Joined the Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, the company has committed to set near-term company-wide emission reductions in line with climate science with the SBTi.
  • Joined the Sustainable Markets Initiative (SMI) of Manufacture 2030, fostering collaboration with the company’s pharma partners to implement tangible measures for decarbonizing healthcare supply chains.

Social:

  • Strengthened the company’s commitment to social accountability through the implementation of robust policies addressing labor and human rights. Nurtured an agile workforce by embracing diversity across age and gender at all management levels, with dedicated efforts toward empowering women throughout the organization.

Governance:

  • Established the 'Sustainability Governance Council' to seamlessly integrate sustainability matters into the company’s business strategy and oversee the effective enforcement of the sustainability mandate.

This report underscores the company’s dedication to sustainability and exemplifies the progress made, reinforcing Sai Life Sciences' position as a frontrunner in the pursuit of environmentally conscious and socially responsible business practices.

Share article

More News

2026.01.28

Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a strategic collaboration that establishes Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. Under this collaboration, Mabtech and Sai will […]
Read more

2026.01.12

Sai Life Sciences laboratories achieve Green Lab Certification

Sai Life Sciences has achieved Green Lab Certification for two PR&D laboratories and two Medicinal Chemistry laboratories under the My Green Lab (MGL) framework, with a compliance score of over 98%.The certification reflects the company’s systematic efforts to integrate sustainability into daily laboratory operations, with measurable reductions in energy consumption, water usage, waste generation, and […]
Read more

2025.12.19

Sai Life Sciences Releases Sustainability Report 2025

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the […]
Read more

2025.12.15

Pushing Boundaries in Organic Chemistry: IISc Prof. Santanu Mukherjee at Sai Life Sciences

As part of Sai Life Sciences’ ongoing initiative to foster meaningful scientific engagement through interactions with distinguished researchers, Prof. Santanu Mukherjee, Professor in the Department of Organic Chemistry at IISc Bangalore, visited our Integrated R&D campus for a full-day programme of knowledge exchange. He delivered an insightful masterclass on his group’s work in enantioselective desymmetrization—a […]
Read more

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more